| 骨质疏松症的药物治疗 |
| |
| 引用本文： | 冯颖瑜,修玲玲,苏 磊.骨质疏松症的药物治疗[J].医学综述,2014(1):105-109. |
| |
| 作者姓名： | 冯颖瑜 修玲玲 苏 磊 |
| |
| 作者单位： | [1]中山大学附属第一医院,内分泌科广州510080 [2]中山大学附属第一医院老年病科,广州510080 |
| |
| 摘 要： | 骨质疏松症是一种骨退行性病变,其发生主要与骨吸收和骨重建失衡有关。根据骨质疏松症的发病机制的不同,临床治疗药物主要分为基本补充剂、抗骨吸收药物和促骨形成药物。钙剂和维生素D是药物治疗的基础;抗骨吸收药物包括双磷酸盐、雌激素及其受体调节剂、降钙素;甲状旁腺激素为促骨形成药物;锶盐、维生素K2等兼有抗骨吸收和促骨形成的作用。特殊人群以及不同类型的骨质疏松症治疗要注意药物的适用性和针对性。
|
| 关 键 词： | 骨质疏松症 治疗 药物 抗骨吸收剂 促骨形成剂 |
Drug Therapy for Osteoporosis |
| |
| Institution: | FENG Ying-yu,XIU Ling-ling ,SU Lei ( 1. Department of Endo- crinology, 2. Department of Gerontology, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China ) |
| |
| Abstract: | Osteoporosis is a disease of bone degeneration resulted from the imbalance of bone resorption and bone formation. Clinical medicines are divided into three categories according to the pathogenesis：basie supplements, anti-resorptive agents and bone formation-accelerating agents. Calcium and vitamin D are basic supplements, anti-resorptive agents include bisphosphonate, HRT/SERMs and calcitonin. PTH is the bone- forming agent while strunium ranelate and vitamin K2 have both anti-resorptive and bone-forming effects. Drugs treatment should be more applicable and specific when administered to different types of osteoporosis. |
| |
| Keywords: | Osteoporosis Therapy Drug Anti-resorptive agents Bone formation-accelerating agents |
| 本文献已被 CNKI 维普 等数据库收录！ |
|
